1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow ANCA Associated Vasculitis: new trials by email Literature Review of ANCA Associated Vasculitis trials Research Report on ANCA Associated Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis Rituximab - Systemic Lupus Erythematosus, ANCA Associated Vasculitis | Phase 2 | Completed | Cambridge University Hospitals NHS Foundation Trust | 20 | 2002-03-01 | 2006-02-17 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Lupus Erythematosus, Systemic (1) · Vasculitis (1)
Autoimmune Diseases (1) · Cardiovascular Diseases (1) · Connective Tissue Diseases (1) · Immune System Diseases (1) · Skin Diseases (1) · Skin Diseases, Vascular (1) · Skin and Connective Tissue Diseases (1) · Systemic Vasculitis (1) · Vascular Diseases (1)
Rituximab (1)
Cambridge University Hospitals NHS Foundation Trust (1)
United Kingdom (1)
David Jayne (1) · Ken Smith (1)